Testing effectiveness (Phase 2)Looking for participantsNCT07223229
What this trial is testing
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Who this might be right for
Non-segmental Vitiligo
Elixiron Immunotherapeutics (Hong Kong) Ltd. 45